“…The majority of participants had breast cancer (62.46%, n = 2748). Four of the included articles examined IPV in breast cancer survivors)Canady et al, 2010; Fouladi et al, 2021; Sawin et al, 2009; Sawin & Parker, 2011. (Two articles on cervix cancer (Coker et al, 2000; Thananowan & Vongsirimas, 2016), one article on both breast and cervix cancer (Jetelina et al, 2020) and, one article on the cervix, breast, gynaecological and colorectal cancers (more than half of the samples were breast cancer survivors) (Coker et al, 2017).…”